drugset / Trial / NCT03873337

Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI)

NCT03873337

NaSingle-groupOpen-labelTreatment

Summary

Due to the pandemic, this study was modified from a randomized clinical trial to test the feasibility, initial efficacy, and mechanisms of action of our PTSC-S intervention to a feasibility and acceptability test of our intervention when delivered via telehealth in a single group, within-subjects design.

Timeline

Start
2019-04-22
Primary completion
2022-01-10
Completion
2022-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown Other